NDC 61364-181-01 - Rapivab
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61364-181
- Requested NDC
- 61364-181-01
- Package NDCs from labels
- 61364-181-01, 61364-181-03
- Manufacturer
- Seqirus USA Inc. | Alcami Missouri Corporation | Cilag Ag | Eurofins Lancaster Laboratories Inc. | Galbraith Labs Inc. | Jubilant HollisterStier LLC | Patheon Manufacturing Services LLC | Siegfried USA, LLC
- Effective date
- 2020-06-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rapivab | Seqirus USA Inc. | Alcami Missouri Corporation | Cilag Ag | Eurofins Lancaster Laboratories Inc. | Galbraith Labs Inc. | Jubilant HollisterStier LLC | Patheon Manufacturing Services LLC | Siegfried USA, LLC | 2020-06-17 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61364-181-03 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-0ff0-fd44-e053-dadaa90aa01b | These highlights do not include all the information needed to use RAPIVAB safely and effectively. See full prescribing information for RAPIVAB. RAPIVAB ® (peramivir injection), for intravenous use Initial U.S. Approval: [2014] |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61364-181-01 | Rapivab | 20 mL in 1 VIAL, GLASS | SOLUTION | 20 | 7 | |
| 61364-181-03 | Rapivab | 3 in 1 CARTON | SOLUTION | 3 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61364-181-01 | ML - Milliliter | 61364-181 | 66173613-ff45-49b6-bb5f-bf3cd2a70494 | 1 | 2015-01-05 |
| 61364-181-03 | ML - Milliliter | 61364-181 | 929831d0-4474-4b87-9a3a-7b79a9b33101 | 1 | 2015-01-05 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Peramivir | ACTIVE INGREDIENT | QW7Y7ZR15U | RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.] | 2 | |
| Peramivir Anhydrous | ACTIVE MOIETY | 9ZS94HQO3B | RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.] | 2 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.] | 2 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.] | 2 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.] | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2a96096d-43cc-49b7-af53-b53c17f41001 | 2014-07-25 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.